Vitamin D in the cancer patient

Kurt A. Kennel, Matthew M Drake

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose of review: To briefly review recent work within the vitamin D and cancer field, whereas also providing context relating how these findings may impact clinical care and future research efforts. Recent findings: Vitamin D has now been convincingly shown both in vitro and in preclinical animal models to alter the differentiation, proliferation, and apoptosis of cancer cells. Whether vitamin D prevents cancer in humans or limits cancer progression, however, remain open questions. Epidemiologic and observational data relating circulating 25(OH)D levels and cancer risk suggest an inverse relationship for most cancers including breast, colorectal, leukemia and lymphoma, and prostate, although for each malignancy there also exist studies that have failed to demonstrate such an inverse relationship. Likewise, a more recent report failed to confirm a previously reported association of increased pancreatic cancer risk in patients with higher 25(OH)D levels. A large prospective study in which patients aged at least 50 years receive 2000 IU vitamin D3 daily for 5 years, with cancer as a primary endpoint, has recently been launched. Summary: Although much effort has attempted to delineate a causal relationship between vitamin D and a wide array of human cancers, we await large-scale randomized controlled trial data for definitive answers.

Original languageEnglish (US)
Pages (from-to)272-277
Number of pages6
JournalCurrent Opinion in Supportive and Palliative Care
Volume7
Issue number3
DOIs
StatePublished - Sep 2013

Fingerprint

Vitamin D
Neoplasms
Cholecalciferol
Pancreatic Neoplasms
Prostate
Lymphoma
Leukemia
Randomized Controlled Trials
Animal Models
Prospective Studies
Apoptosis
Breast Neoplasms

Keywords

  • Cancer
  • Observational data
  • Risk
  • Vitamin D

ASJC Scopus subject areas

  • Oncology
  • Medicine(all)
  • Critical Care and Intensive Care Medicine
  • Oncology(nursing)

Cite this

Vitamin D in the cancer patient. / Kennel, Kurt A.; Drake, Matthew M.

In: Current Opinion in Supportive and Palliative Care, Vol. 7, No. 3, 09.2013, p. 272-277.

Research output: Contribution to journalArticle

@article{4b51d4a8409746d38fa15cd293719ed7,
title = "Vitamin D in the cancer patient",
abstract = "Purpose of review: To briefly review recent work within the vitamin D and cancer field, whereas also providing context relating how these findings may impact clinical care and future research efforts. Recent findings: Vitamin D has now been convincingly shown both in vitro and in preclinical animal models to alter the differentiation, proliferation, and apoptosis of cancer cells. Whether vitamin D prevents cancer in humans or limits cancer progression, however, remain open questions. Epidemiologic and observational data relating circulating 25(OH)D levels and cancer risk suggest an inverse relationship for most cancers including breast, colorectal, leukemia and lymphoma, and prostate, although for each malignancy there also exist studies that have failed to demonstrate such an inverse relationship. Likewise, a more recent report failed to confirm a previously reported association of increased pancreatic cancer risk in patients with higher 25(OH)D levels. A large prospective study in which patients aged at least 50 years receive 2000 IU vitamin D3 daily for 5 years, with cancer as a primary endpoint, has recently been launched. Summary: Although much effort has attempted to delineate a causal relationship between vitamin D and a wide array of human cancers, we await large-scale randomized controlled trial data for definitive answers.",
keywords = "Cancer, Observational data, Risk, Vitamin D",
author = "Kennel, {Kurt A.} and Drake, {Matthew M}",
year = "2013",
month = "9",
doi = "10.1097/SPC.0b013e3283640f74",
language = "English (US)",
volume = "7",
pages = "272--277",
journal = "Current Opinion in Supportive and Palliative Care",
issn = "1751-4258",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Vitamin D in the cancer patient

AU - Kennel, Kurt A.

AU - Drake, Matthew M

PY - 2013/9

Y1 - 2013/9

N2 - Purpose of review: To briefly review recent work within the vitamin D and cancer field, whereas also providing context relating how these findings may impact clinical care and future research efforts. Recent findings: Vitamin D has now been convincingly shown both in vitro and in preclinical animal models to alter the differentiation, proliferation, and apoptosis of cancer cells. Whether vitamin D prevents cancer in humans or limits cancer progression, however, remain open questions. Epidemiologic and observational data relating circulating 25(OH)D levels and cancer risk suggest an inverse relationship for most cancers including breast, colorectal, leukemia and lymphoma, and prostate, although for each malignancy there also exist studies that have failed to demonstrate such an inverse relationship. Likewise, a more recent report failed to confirm a previously reported association of increased pancreatic cancer risk in patients with higher 25(OH)D levels. A large prospective study in which patients aged at least 50 years receive 2000 IU vitamin D3 daily for 5 years, with cancer as a primary endpoint, has recently been launched. Summary: Although much effort has attempted to delineate a causal relationship between vitamin D and a wide array of human cancers, we await large-scale randomized controlled trial data for definitive answers.

AB - Purpose of review: To briefly review recent work within the vitamin D and cancer field, whereas also providing context relating how these findings may impact clinical care and future research efforts. Recent findings: Vitamin D has now been convincingly shown both in vitro and in preclinical animal models to alter the differentiation, proliferation, and apoptosis of cancer cells. Whether vitamin D prevents cancer in humans or limits cancer progression, however, remain open questions. Epidemiologic and observational data relating circulating 25(OH)D levels and cancer risk suggest an inverse relationship for most cancers including breast, colorectal, leukemia and lymphoma, and prostate, although for each malignancy there also exist studies that have failed to demonstrate such an inverse relationship. Likewise, a more recent report failed to confirm a previously reported association of increased pancreatic cancer risk in patients with higher 25(OH)D levels. A large prospective study in which patients aged at least 50 years receive 2000 IU vitamin D3 daily for 5 years, with cancer as a primary endpoint, has recently been launched. Summary: Although much effort has attempted to delineate a causal relationship between vitamin D and a wide array of human cancers, we await large-scale randomized controlled trial data for definitive answers.

KW - Cancer

KW - Observational data

KW - Risk

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84887927658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887927658&partnerID=8YFLogxK

U2 - 10.1097/SPC.0b013e3283640f74

DO - 10.1097/SPC.0b013e3283640f74

M3 - Article

C2 - 23912386

AN - SCOPUS:84887927658

VL - 7

SP - 272

EP - 277

JO - Current Opinion in Supportive and Palliative Care

JF - Current Opinion in Supportive and Palliative Care

SN - 1751-4258

IS - 3

ER -